BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6376746)

  • 21. [Major beta-thalassemia and bone marrow allograft. Two cases and a study of the literature].
    Frappaz D; Freycon F; Richard O; Galacteros F; Bertheas MF; Dutou L; Bouteille M
    Pediatrie; 1987; 42(8):637-44. PubMed ID: 3329338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Marrow transplantation for thalassaemia following busulphan and cyclophosphamide.
    Lucarelli G; Polchi P; Galimberti M; Izzi T; Delfini C; Manna M; Agostinelli F; Baronciani D; Giorgi C; Angelucci E
    Lancet; 1985 Jun; 1(8442):1355-7. PubMed ID: 2861312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft.
    Horwitz ME; Barrett AJ; Brown MR; Carter CS; Childs R; Gallin JI; Holland SM; Linton GF; Miller JA; Leitman SF; Read EJ; Malech HL
    N Engl J Med; 2001 Mar; 344(12):881-8. PubMed ID: 11259721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Correction of fatal genetic diseases using bone marrow transplantation. 2].
    Zintl F; Hermann J; Fuchs D; Prager J; Müller A; Reiners B; Füller J
    Kinderarztl Prax; 1991; 59(1-2):10-5. PubMed ID: 2056655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of chronic myelogenous leukemia with allogeneic bone marrow transplantation after preparation with busulfan and cyclophosphamide (BuCy2): an update.
    Brodsky I; Biggs JC; Szer J; Crilley P; Atkinson K; Downs K; Dodds A; Concannon AJ; Avalos BR; Tutschka P
    Semin Oncol; 1993 Aug; 20(4 Suppl 4):27-31; quiz 32. PubMed ID: 8342072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical outcome of allogeneic hematopoietic stem cell transplantation with FLAG sequential busulfan/cyclophosphamide conditioning regimen for refractory/relapsed acute myeloid leukemia].
    Liu W; Li Y; Qiu ZX; Yin Y; Sun YH; Xu WL; Wang Q; Liang ZY; Dong YJ; Wang LH; Cen QN; Wang MJ; Wang WS; Ou JP; Ren HY
    Zhonghua Nei Ke Za Zhi; 2018 Aug; 57(8):576-581. PubMed ID: 30060329
    [No Abstract]   [Full Text] [Related]  

  • 27. Chronic granulomatous disease 100% corrected by displacement bone marrow transplantation from a volunteer unrelated donor.
    Hobbs JR; Monteil M; McCluskey DR; Jurges E; el Tumi M
    Eur J Pediatr; 1992 Nov; 151(11):806-10. PubMed ID: 1468453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allogeneic bone marrow transplantation in an osteopetrosis patient: first report in Thailand.
    Hongeng S; Pakakasama S; Chuansumrit A; Rerkamnuaychoke B; Nitiyanunt P; Suthutvoravut U; Ungkanont A; Hathirat P
    Asian Pac J Allergy Immunol; 1998 Dec; 16(4):193-8. PubMed ID: 10219901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful living-donor liver transplantation for chronic hepatic graft-versus-host disease after bone marrow transplantation for chronic granulomatous disease.
    Yokoyama S; Kasahara M; Fukuda A; Sato S; Mori T; Nakagawa A; Matsui A
    Transplantation; 2008 Jul; 86(2):367-8. PubMed ID: 18645505
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of peripheral blood stem cell transplant with bone marrow transplant in class 3 thalassemic patients.
    Iravani M; Tavakoli E; Babaie MH; Ashouri A; Khatami F; Ghavamzadeh A
    Exp Clin Transplant; 2010 Mar; 8(1):66-73. PubMed ID: 20199374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Donor lymphocyte infusion at unstable mixed chimerism in an allogeneic BMT recipient for chronic granulomatous disease.
    Akioka S; Itoh H; Ueda I; Matsumoto Y; Iwami H; Tsunamoto K; Hibi S; Todo S; Sawada T; Imashuku S
    Bone Marrow Transplant; 1998 Sep; 22(6):609-11. PubMed ID: 9758355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A comparison of toxicity and efficacy between busulfan plus fludarabine and busulfan plus cyclophosphamide for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia].
    Liu H; Fan ZP; Jiang QL; Huang F; Zhou HS; Zhang X; Yu GP; Wu MQ; Sun J; Liu QF
    Zhonghua Nei Ke Za Zhi; 2012 Nov; 51(11):880-4. PubMed ID: 23291027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful Unrelated Cord Blood Stem Cell Transplantation in an X-linked Chronic Granulomatous Disease Patient with Disseminated BCG-induced Infection.
    Lin CJ; Wang SC; Ku CL; Kao JK; Chen M; Liu CS
    Pediatr Neonatol; 2015 Oct; 56(5):346-50. PubMed ID: 23680261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allogeneic hematopoietic stem cell transplant for high-risk adult patients with chronic granulomatous disease: first case report from Iran.
    Ramzi M; Rezvani A; Haghighinejad H
    Exp Clin Transplant; 2014 Oct; 12(5):490-3. PubMed ID: 25299376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Second marrow transplantation following high dose busulfan, etoposide, and Ara-C after testicular relapse in a patient with AML].
    Matsue K; Tohi T; Masauji N; Tsukuda K
    Rinsho Ketsueki; 1992 Mar; 33(3):338-42. PubMed ID: 1578638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of infant leukemia with busulfan, cyclophosphamide +/- etoposide and bone marrow transplantation.
    Emminger W; Emminger-Schmidmeier W; Haas OA; Urban C; Ambros P; Peters C; Mann G; Fink FM; Ferstl G; Höcker P
    Bone Marrow Transplant; 1992 May; 9(5):313-8. PubMed ID: 1617314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Single-Center Experience Comparing Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning with Myeloablative Busulfan, Cyclophosphamide, and Antithymocyte Globulin for Chronic Granulomatous Disease.
    Khandelwal P; Bleesing JJ; Davies SM; Marsh RA
    Biol Blood Marrow Transplant; 2016 Nov; 22(11):2011-2018. PubMed ID: 27543157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Results of allogeneic bone marrow transplant in chronic myeloid leukaemia following conditioning with busulfan and cyclophosphamide.
    Saikia TK; Advani SH; Parikh PM; Bapna A; Somjee S; Mukhopadhyay A; Gopal R; Nair CN
    J Assoc Physicians India; 1999 Aug; 47(8):770-3. PubMed ID: 10778619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serial transplantation resulting in tolerance to an unrelated cord blood graft.
    Goebel WS; Nelson RP; Brahmi Z; Gowan DJ; Towell PJ; Robertson KA; Haut PR
    Transplantation; 2006 Jun; 81(11):1596-9. PubMed ID: 16770250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone marrow transplantation for an infant with neutrophil dysfunction.
    Camitta BM; Quesenberry PJ; Parkman R; Boxer LA; Stossel TP; Cassady JR; Rappeport JM; Nathan DG
    Exp Hematol; 1977 Mar; 5(2):109-16. PubMed ID: 321233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.